MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

AIM ImmunoTech Inc. (AIM)

AIM ImmunoTech Inc. (AIM)

|||

Balance Sheets Overview

Current Ratio
210.92%
Quick Ratio
210.92%
Cash Ratio
200.16%
Debt to Asset Ratio
39.17%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Prepaid expenses and other curre...
    • Other assets
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Current portion of note payable,...
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-09-30
2025-06-30
Cash and cash equivalents
9,900
5,816
2,347
476
Marketable investments
64
63
62
359
Prepaid expenses and other current assets
468
335
166
190
Total current assets
10,432
6,214
2,575
1,025
Property and equipment, net
54
62
80
89
Right of use asset, net
260
320
436
496
Patent and trademark rights, net
1,714
1,662
2,041
2,168
Other assets
271
327
362
351
Total assets
12,731
8,585
5,494
4,129
Accounts payable
480
1,215
1,252
7,297
Accrued expenses
586
671
679
573
Current portion of operating lease liability
259
255
232
233
Current portion of note payable, net
3,621
4,004
1,880
2,290
Total current liabilities
4,946
6,145
4,043
10,393
Operating lease liability
41
105
226
282
Preferred stock, value-Series BConvertible Preferred Stock
-
-
-
0
Warrant liability
-
-
7,302
-
Long-term note payable
-
210
-
-
Preferred stock, value-Series AJunior Participating Preferred Stock
-
-
-
0
Total liabilities
4,987
6,460
11,571
10,675
Common stock, 0.001 par value, authorized shares - 350,000,000 issued and outstanding shares 28,990,073 and 3,069,875 as of june 30, 2026 and december 31, 2025, respectively
29
8
3
1
Additional paid-in capital
455,312
445,926
430,531
426,780
Accumulated deficit
-447,597
-443,809
-436,611
-433,327
Total stockholders equity (deficit)
7,744
2,125
-6,077
-6,546
Total liabilities and stockholders equity
12,731
8,585
5,494
4,129
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$9,900K (1979.83%↑ Y/Y)Prepaid expenses andother current assets$468K (146.32%↑ Y/Y)Marketable investments$64K (-82.17%↓ Y/Y)Total current assets$10,432K (917.76%↑ Y/Y)Patent and trademarkrights, net$1,714K (-20.94%↓ Y/Y)Other assets$271K (-22.79%↓ Y/Y)Right of use asset, net$260K (-47.58%↓ Y/Y)Property and equipment,net$54K (-39.33%↓ Y/Y)Total assets$12,731K (208.33%↑ Y/Y)Total liabilities andstockholders equity$12,731K (208.33%↑ Y/Y)Total stockholdersequity (deficit)$7,744K (218.30%↑ Y/Y)Total liabilities$4,987K (-53.28%↓ Y/Y)Accumulated deficit-$447,597K (-3.29%↓ Y/Y)Additional paid-in capital$455,312K (6.69%↑ Y/Y)Total currentliabilities$4,946K (-52.41%↓ Y/Y)Operating lease liability$41K (-85.46%↓ Y/Y)Common stock, 0.001 parvalue, authorized...$29K (2800.00%↑ Y/Y)Current portion of notepayable, net$3,621K (58.12%↑ Y/Y)Accrued expenses$586K (2.27%↑ Y/Y)Accounts payable$480K (-93.42%↓ Y/Y)Current portion ofoperating lease liability$259K (11.16%↑ Y/Y)